Del Sette Capital Management, LLC Crispr Therapeutics Ag Transaction History
Del Sette Capital Management, LLC
- $150 Million
- Q3 2025
A detailed history of Del Sette Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Del Sette Capital Management, LLC holds 62,494 shares of CRSP stock, worth $3.46 Million. This represents 2.69% of its overall portfolio holdings.
Number of Shares
62,494
Previous 63,843
2.11%
Holding current value
$3.46 Million
Previous $3.11 Million
30.43%
% of portfolio
2.69%
Previous 2.28%
Shares
6 transactions
Others Institutions Holding CRSP
# of Institutions
546Shares Held
67.7MCall Options Held
3.5MPut Options Held
3.08M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.79MShares$541 Million4.45% of portfolio
-
Capital International Investors Los Angeles, CA5.65MShares$313 Million0.06% of portfolio
-
Orbis Allan Gray LTD Hamilton, D04.98MShares$276 Million1.8% of portfolio
-
State Street Corp Boston, MA4.01MShares$222 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.28MShares$182 Million0.13% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.32B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....